BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251027
DTEND;VALUE=DATE:20251030
DTSTAMP:20260515T035144
CREATED:20250604T112925Z
LAST-MODIFIED:20250805T122256Z
UID:41188-1761523200-1761782399@www.pharmajournalist.com
SUMMARY:13th IMPACCT Real-World Evidence Summit
DESCRIPTION:With CMS introducing new guidance for RWD studies\, the FDA announcing a new RWE Center\, and RWD becoming more accessible\, it is clear that RWE will play an increasingly pivotal role in the drug development lifecycle. But uncertainties still remain for the experts applying RWE. \nReturning to Boston\, the 13th IMPACCT Real-World Evidence Summit is the only industry-focused meeting dedicated to uniting RWE experts to consolidate and optimize their RWE strategies. Join 140+ industry pioneers from top pharma and biotech companies\, as they share real-world case studies\, the latest industry insights\, and transformative strategies to upskill your team with the knowledge to advance your RWE utility. \nFind out more \nWhat Can You Expect? \n\nHear how Pfizer are using AI to refine data quality through optimized data generation\, data pipeline automation\, and data augmentation.\nIdentify key tokenization methods to ensure consistency\, interoperability\, and improved data utility for regulatory and payer decision making with AstraZeneca.\nLearn how Abbvie are empowering their value and evidence teams with timely insights to support market access and strategic planning.\nBuild a centralized evidence strategy that aligns your cross-functional teams and ensures consistent objectives with Otsuka and Ionis Pharmaceuticals.\n\nDiscover the extensive list of sessions\, speakers and case studies in our agenda! \nSeize your opportunity to gain invaluable industry insights\, address challenges and foster connections\, to perfect your data-quality and enhance your RWE approaches.
URL:http://www.pharmajournalist.com/event/13th-impacct-real-world-evidence-summit/
LOCATION:Hilton Boston Logan Airport\, One Hotel Dr\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251027
DTEND;VALUE=DATE:20251031
DTSTAMP:20260515T035144
CREATED:20250613T093335Z
LAST-MODIFIED:20250613T102703Z
UID:41269-1761523200-1761868799@www.pharmajournalist.com
SUMMARY:8th TPD & Induced Proximity Summit
DESCRIPTION: Returning as the industry’s definitive forum from early discovery to clinical development\, the 8th Annual TPD & Induced Proximity Summit is the world’s largest and longest-standing forum for proximity-based modalities\, enabling you to fully immerse yourself in the breadth and depth of cutting-edge induced proximity therapeutic development. \nFeaturing key leaders such as Arvinas\, Nurix Therapeutics\, C4 Therapeutics\, and innovative newcomers including Larkspur Bio\, Magnet Biomedicine\, TrimTech Therapeutics\, as well as the co-founders of TPD\, Craig Crews and Ray Deshaies\, this is your ultimate meeting to hear the latest clinical data\, forge strategic relationships\, and capitalize on the huge opportunity for this modality to treat patients with high unmet clinical need. \nDownload the event guide for full details: https://ter.li/i9k5iz
URL:http://www.pharmajournalist.com/event/8th-tpd-induced-proximity-summit/
LOCATION:The Westin Boston Seaport District\, 425 Summer Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR